Hussman Strategic Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-21,000
| Closed | -$316K | – | 290 |
|
|
2024
Q3 | $316K | Hold |
21,000
| – | – | 0.08% | 181 |
|
|
2024
Q2 | $601K | Hold |
21,000
| – | – | 0.17% | 181 |
|
|
2024
Q1 | $614K | Hold |
21,000
| – | – | 0.14% | 175 |
|
|
2023
Q4 | $709K | Sell |
21,000
-5,000
| -19% | -$169K | 0.16% | 172 |
|
|
2023
Q3 | $798K | Hold |
26,000
| – | – | 0.15% | 222 |
|
|
2023
Q2 | $1.04M | Sell |
26,000
-20,800
| -44% | -$833K | 0.19% | 211 |
|
|
2023
Q1 | $1.91M | Hold |
46,800
| – | – | 0.3% | 138 |
|
|
2022
Q4 | $1.81M | Buy |
+46,800
| New | +$1.81M | 0.29% | 138 |
|
|
2022
Q1 | – | Sell |
-5,200
| Closed | -$313K | – | 345 |
|
|
2021
Q4 | $313K | Sell |
5,200
-1,000
| -16% | -$60.2K | 0.07% | 277 |
|
|
2021
Q3 | $347K | Sell |
6,200
-6,200
| -50% | -$347K | 0.08% | 269 |
|
|
2021
Q2 | $752K | Buy |
+12,400
| New | +$752K | 0.16% | 224 |
|